Efficacy and safety of perampanel for epilepsy: a systematic review and meta-analysis of real-world studies

CONCLUSIONS: Perampanel might be an effective anti-epileptic drug in both children/adolescents and adults when used as an adjunct therapy. More data is required to comment on its use as monotherapy. Careful monitoring for psychiatric problems and behavioral disturbances is required, both prior to initiating treatment as well as during the course of management. Studies with long-term follow-up may are needed to confirm the findings of this meta-analysis.PMID:37458642 | DOI:10.26355/eurrev_202307_32957

Source: European Review for Medical and Pharmacological Sciences - July 17, 2023 Category: Drugs & Pharmacology Authors: P-F Fan C Zhuo M Huang Source Type: research